APA

Green A. J., Gelfand J. M., Cree B. A., Bevan C., Boscardin W. J., Mei F., Inman J., Arnow S., Devereux M., Abounasr A., Nobuta H., Zhu A., Friessen M., Gerona R., von Büdingen H. C., Henry R. G., Hauser S. L. & Chan J. R. (20180924). Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. : Lancet (London, England).

Chicago

Green Ari J, Gelfand Jeffrey M, Cree Bruce A, Bevan Carolyn, Boscardin W John, Mei Feng, Inman Justin, Arnow Sam, Devereux Michael, Abounasr Aya, Nobuta Hiroko, Zhu Alyssa, Friessen Matt, Gerona Roy, von Büdingen Hans Christian, Henry Roland G, Hauser Stephen L and Chan Jonah R. 20180924. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. : Lancet (London, England).

Harvard

Green A. J., Gelfand J. M., Cree B. A., Bevan C., Boscardin W. J., Mei F., Inman J., Arnow S., Devereux M., Abounasr A., Nobuta H., Zhu A., Friessen M., Gerona R., von Büdingen H. C., Henry R. G., Hauser S. L. and Chan J. R. (20180924). Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. : Lancet (London, England).

MLA

Green Ari J, Gelfand Jeffrey M, Cree Bruce A, Bevan Carolyn, Boscardin W John, Mei Feng, Inman Justin, Arnow Sam, Devereux Michael, Abounasr Aya, Nobuta Hiroko, Zhu Alyssa, Friessen Matt, Gerona Roy, von Büdingen Hans Christian, Henry Roland G, Hauser Stephen L and Chan Jonah R. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. : Lancet (London, England). 20180924.